Skip to main content

Articles

Page 3 of 40

  1. Metabolic syndrome (MetS) is a group of metabolic abnormalities characterised by hypertension, central obesity, dyslipidaemia and dysregulation of blood glucose, associated with the risk of diabetes, cardiovas...

    Authors: Elena Raya-Cano, Rafael Molina-Luque, Manuel Vaquero-Abellán, Guillermo Molina-Recio, Rocío Jiménez-Mérida and Manuel Romero-Saldaña
    Citation: Diabetology & Metabolic Syndrome 2023 15:220
  2. Glucose fluctuations (GF) are a risk factor for cardiovascular complications associated with type 2 diabetes. However, there is a lack of adequate research on the effect of GF on myocardial fibrosis and the un...

    Authors: Lei Zhang, Huan-Huan Liu, Fan Yang, Zhi-Yuan Zhang, Zhen-Ye Zhang, Xiao-Xi Zhao, Ling-Ling Qian, Shi-Peng Dang and Ru-Xing Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:217
  3. Cardiovascular risk prediction models encompass numerous CVD risk factors. Available prediction models were developed from non-Asian cohorts hence we decided to evaluate the performance of the ASCVD risk estim...

    Authors: Ian Osoro, Ranjeet Kumar and Amit Sharma
    Citation: Diabetology & Metabolic Syndrome 2023 15:216
  4. Studies on the association of gestational diabetes mellitus (GDM) with osteoporosis, and bone mineral density (BMD) have been inconsistent. The aim of this study was to investigate the association of a history...

    Authors: Boqi Lu and Liping Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:215
  5. Pemafibrate has been reported to ameliorate lipid profiles and liver dysfunction. However, which patients derive benefit from the hepatoprotective effects of pemafibrate is unclear.

    Authors: Hiroshi Nomoto, Kenichi Kito, Hiroshi Iesaka, Takahisa Handa, Shingo Yanagiya, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, So Nagai, Ichiro Sakuma, Akinobu Nakamura and Tatsuya Atsumi
    Citation: Diabetology & Metabolic Syndrome 2023 15:214
  6. Diabetic foot ulcers (DFUs) represent a significant foot-related concern for patients with multiple co-morbidities, and surgical intervention is often employed. Notably, peripheral nerve block anesthesia (PNB)...

    Authors: Gehua Zhu, Jiamin Xu, Hanying Dai, Dinghong Min and Guanghua Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:213
  7. Contradictory relationships have been observed between thyroid function and gestational diabetes mellitus (GDM). Previous studies have indicated that pre-pregnancy BMI (pBMI) could modify their relationships. ...

    Authors: Honglin Sun, Yibo Zhou, Jia Liu, Ying Wang and Guang Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:212
  8. Observational research reported the underlying correlation of metabolic syndrome (MetS) and its components with rotator cuff tendinopathy (RCT), but their causality remained unclear. This study aimed to invest...

    Authors: Ziqin Cao, Qiangxiang Li, Yajia Li and Jianhuang Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:211
  9. Both type 2 diabetes mellitus (T2DM) and frailty are strongly associated with congestive heart failure (CHF). Individuals with T2DM and CHF have a high frailty burden. The association of frailty with HF, all-c...

    Authors: Yu-Nan Qin and Xiao-Pu Zheng
    Citation: Diabetology & Metabolic Syndrome 2023 15:210
  10. Time-restricted eating (TRE), a feasible form of intermittent fasting, has been proven to benefit metabolic health in animal models and humans. To our knowledge, specific guidance on the appropriate period for...

    Authors: Zhongbiao Nie, Jiaming Xu, Yinchu Cheng, Zhihong Li, Ran Zhang, Wentao Zhang and Libo Zhao
    Citation: Diabetology & Metabolic Syndrome 2023 15:209
  11. The co-occurrence of cardiometabolic diseases (CMDs) is increasingly prevalent and has been associated with an additive risk of dementia in older adults, but the extent to which this risk can be offset by a he...

    Authors: Sizheng Xiong, Ningxin Hou, Feifei Tang, Jun Li and Hongping Deng
    Citation: Diabetology & Metabolic Syndrome 2023 15:208
  12. The prognostic nutritional index (PNI) and different glucose metabolisms have been separately reported to be correlated with long-term prognosis in patients with acute myocardial infarction (AMI) undergoing pe...

    Authors: Xuebin Ling, Chufen Lin, Jin Liu, Yibo He, Yongquan Yang, Na Lu, Wei Jie, Yong Liu, Shiqun Chen and Junli Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:207
  13. Maturity-onset diabetes of the young type 2 (MODY2) is a rare genetic disorder characterized as mild fasting hyperglycemia with low risk of vascular complications caused by glucokinase gene mutation. This stud...

    Authors: Jieying Liu, Ziyan Xie, Junling Fu, Miao Yu, Tong Wang, Cuijuan Qi, Peng Liu, Xiangyi Hui, Dongmei Wang, Lu Ding, Qian Zhang, Ting Xie and Xinhua Xiao
    Citation: Diabetology & Metabolic Syndrome 2023 15:206
  14. Advanced hybrid closed loop (AHCL) system provides both automated basal rate and correction boluses to keep glycemic values in a target range.

    Authors: Nancy Samir Elbarbary and Eman Abdel Rahman Ismail
    Citation: Diabetology & Metabolic Syndrome 2023 15:205
  15. The impact of triglyceride-glucose (TyG) index, a surrogate marker for insulin resistance, on the risk of cardiovascular disease (CVD) in general populations remains controversial. We aimed to comprehensively ...

    Authors: Yiming Wan, Ziliang Zhang, Yong Ling, Hui Cui, Zihan Tao, Jianfeng Pei, Aikedan Maimaiti, Haifan Bai, Yiling Wu, Jing Li, Genming Zhao and Maryam Zaid
    Citation: Diabetology & Metabolic Syndrome 2023 15:204
  16. Diabetes mellitus (DM) is associated with severe forms of COVID-19 but little is known about the diabetes—related phenotype considering pre-admission, on-admission and data covering the entire hospitalization ...

    Authors: Lais Isidoro Alves, Adriana Aparecida Bosco, Adriana Aparecida Rosa, Marcia Regina Soares Correia, Sergio Russo Matioli and Maria Elizabeth Rossi da Silva
    Citation: Diabetology & Metabolic Syndrome 2023 15:203
  17. Serum uric acid levels are higher in patients with type 2 diabetes and prediabetes compared to healthy individuals, and hyperuricemia causes a significant rate of complications and mortality through heart and ...

    Authors: Yinyuan You, Yu Zhao, Mujuan Chen, Ying Pan and Zhenhui Luo
    Citation: Diabetology & Metabolic Syndrome 2023 15:202
  18. The research was aimed to evaluate the subclinical left ventricular (LV) myocardial systolic dysfunction in T2DM patients with or without hypertension (HT) by global and segmental myocardial work (MW).

    Authors: Guang-An Li, Jun Huang, Xiao Sheng and Li Fan
    Citation: Diabetology & Metabolic Syndrome 2023 15:200
  19. Hypoglycemia is one of the most common complications in patients with DN during hemodialysis. The purpose of the study is to construct a clinical automatic calculation to predict risk of hypoglycemia during he...

    Authors: Rui-Ting Zhang, Yu Liu, Ke-Ke Lin, Wan-Ning Jia, Quan-Ying Wu, Jing Wang and Xiao-Yan Bai
    Citation: Diabetology & Metabolic Syndrome 2023 15:199
  20. Patients with diabetic ketoacidosis (DKA), a potentially fatal complication of type 1 diabetes, have hyperglycemia, ketonemia and metabolic acidosis. Blood glucose and blood ketone results are often used to tr...

    Authors: Eric S. Kilpatrick, Alexandra E. Butler, Sawsan Saeed, Naji Alamuddin, Stephen L. Atkin and David B. Sacks
    Citation: Diabetology & Metabolic Syndrome 2023 15:198
  21. To investigate the diagnostic value of serum lncRNA growth arrest-specific transcript 5 (lncRNA GAS5) and microRNA-21 (miR-21) in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN), an...

    Authors: He Sun, Tong Chen, Xin Li, Yonghong Zhu, Shuang Zhang, Ping He, Yali Peng and Qiuling Fan
    Citation: Diabetology & Metabolic Syndrome 2023 15:197
  22. Exposure to a hyperglycemic environment during prenatal life may result in an unfavorable metabolic profile later in adulthood. We aimed to assess whether fatty liver index, a non-invasive indicator of nonalco...

    Authors: Cedric A. Korpijaakko, Johan G. Eriksson, Hannu Kautiainen, Miira M. Klemetti and Merja K. Laine
    Citation: Diabetology & Metabolic Syndrome 2023 15:196
  23. This study aims to investigate the relationship between two novel inflammatory markers, namely, the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune Inflammatory Index (SII), as well as the ...

    Authors: Fanliang Kong, Junhao Huang, Chunhua Xu, Tingyuan Huang, Grace Wen and Wenke Cheng
    Citation: Diabetology & Metabolic Syndrome 2023 15:195
  24. The available evidence regarding the association of antioxidants, minerals, and vitamins with the risk of metabolic syndrome (MetS) traits is currently limited and inconsistent. Therefore, the purpose of this ...

    Authors: Junxian Li and Fengju Song
    Citation: Diabetology & Metabolic Syndrome 2023 15:194
  25. The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare resources. Yet the impact of COVID-19 on diabetes outpatients ...

    Authors: Jessica C.G. Bak, Erik H. Serné, Rolf H.H. Groenwold, Harold W. de Valk, Mark H.H. Kramer, Max Nieuwdorp and Carianne L. Verheugt
    Citation: Diabetology & Metabolic Syndrome 2023 15:193
  26. The prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) across body mass index (BMI) categories in patients with acute myocardial infarction (AMI) is unclear. We aimed to assess the predi...

    Authors: Man Wang, Ning Cao, Li Zhou, Wen Su, Hui Chen and Hongwei Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:192
  27. Noni is a fruit with potential medicinal use preventing elevated blood glucose levels in diabetes mellitus. Its effects have been attributed to an antioxidant property in several other diseases. However, the e...

    Authors: Débora de Oliveira Fernandes, Fernanda Gracia César, Bruno Pereira Melo, Jéssica da Silva Faria Brandão, Kelvin Jaques dos Santos, Marcelo Teixeira de Andrade, Marisa Cristina da Fonseca Casteluber, Moisés Vieira de Carvalho, Luiz Alexandre Medrado de Barcellos, Danusa Dias Soares and Juliana Bohnen Guimarães
    Citation: Diabetology & Metabolic Syndrome 2023 15:191
  28. Glycaemic control of Type 1 Diabetes Mellitus (T1DM) remains a challenge due to hypoglycaemic episodes and the burden of insulin self-management. Advancements have been made with the development of automated i...

    Authors: Amanda Godoi, Isabela Reis Marques, Eduardo M. H. Padrão, Ashwin Mahesh, Larissa C. Hespanhol, José Eduardo Riceto Loyola Júnior, Isabela A. F. de Souza, Vittoria C. S. Moreira, Caroliny H. Silva, Isabele A. Miyawaki, Christi Oommen, Cintia Gomes, Ariadne C. Silva, Kavita Advani and Joao Roberto de Sa
    Citation: Diabetology & Metabolic Syndrome 2023 15:190
  29. In this cross-sectional study, we aimed to evaluate metabolic control, adherence to a gluten-free diet (GFD), and quality of life (QoL) in individuals with type 1 diabetes (T1D) and celiac disease (CD).

    Authors: Ayman A. Al Hayek, Wael M. Al Zahrani, Hamad M. AlAblani and Mohamed A. Al Dawish
    Citation: Diabetology & Metabolic Syndrome 2023 15:189
  30. Epicardial adipose tissue (EAT) is a type of ectopic fat with endocrine and paracrine functions. Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that responds to environmental stimul...

    Authors: Yu-Cheng Cheng, Wei-Chun Ma, Yu-Hsuan Li, Junyi Wu, Kae-Woei Liang, Wen-Jane Lee, Hsiu-Chen Liu, Wayne Huey-Herng Sheu and I-Te Lee
    Citation: Diabetology & Metabolic Syndrome 2023 15:188
  31. The associations between the triglyceride–glucose (TyG) index with subsequent stroke in American adults are unknown. The aim of this study was to determine the associations between baseline and trajectories of...

    Authors: Xinyi Wang, Qiyu Liu, Tongxin Wang, Wende Tian, Xuanye Chen, Jie Zhang, Qiuyi Li, Dan Ma, Lin Zhao, Zhuo Chen, Hao Xu and Keji Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:187
  32. Heart failure is closely correlated with diabetic cardiomyopathy (DCM) and can lead to mortality. Celastrol has long been utilized for the treatment of immune and inflammatory disorders. However, whether celas...

    Authors: Xuyong Zhao, Bingwu Huang, Jianhua Zhang, Wenjun Xiang and Ning Zhu
    Citation: Diabetology & Metabolic Syndrome 2023 15:186
  33. This study aimed to determine the association between glycemic variability (GV) and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19).

    Authors: Salma Ali El Chab Parolin, Rebecca Benicio Stocco, Julia do Carmo Kneipp Lopes, Marcos Roberto Curcio Pereira, Milena Massae Yamashita, Maria Eduarda Domareski Goulart, Henrique Demeneck, Marcia Olandoski, Larissa Hermann de Souza Nunes, Victor Keniche Morisawa, Luiz Augusto Fanhani Cracco, Isabela Busto Silva, Jarbas Silva Motta Júnior, Daniela Veit Barreto, Gustavo Lenci Marques, Thyago Proença de Moraes…
    Citation: Diabetology & Metabolic Syndrome 2023 15:185
  34. Although the effect of Vitamin D Supplementation (Vit D) on several chronic diseases has been well conceded, its role in diabetes remains ambiguous. The present study investigated the interactive effects of Ae...

    Authors: Zahra Hoseini, Nasser Behpour and Rastegar Hoseini
    Citation: Diabetology & Metabolic Syndrome 2023 15:184
  35. The association between composite dietary antioxidant index (CDAI) and diabetes remains unknown. Our study was to investigate the association of CDAI with diabetes.

    Authors: Xiaojie Chen, He Lu, Yingwei Chen, Haiqiang Sang, Yi Tang and Yifan Zhao
    Citation: Diabetology & Metabolic Syndrome 2023 15:183
  36. Lipodystrophies are a heterogeneous group of diseases characterized by the selective loss of subcutaneous adipose tissue and ectopic fat deposition in different organs, including the liver. This study aimed to...

    Authors: Luiz F. Viola, Cynthia M. Valerio, João M. Araujo-Neto, Fabio F. Santos, Felipe Matsuura, Rodrigo O. Moreira and Amélio F. Godoy-Matos
    Citation: Diabetology & Metabolic Syndrome 2023 15:182
  37. The triglyceride and glucose (TyG) index has been considered a simple surrogate marker of insulin resistance, related to a high risk of mortality. However, few studies have investigated the specific relationsh...

    Authors: Haiyu Li, Yaohui Jiang, Xin Su and Zhe Meng
    Citation: Diabetology & Metabolic Syndrome 2023 15:181
  38. C-reactive protein(CRP), is an inflammatory marker that weaken leptin bioavailability and insulin sensitivity to disturb energy and glucose metabolism. Polycystic ovary syndrome (PCOS) exhibit a metabolic comp...

    Authors: Ke Li, Lingling Hu, Xinrun Li, Zhibin Yuan, Jia He, Dongfang Liu, Gangyi Yang and Lei Yuan
    Citation: Diabetology & Metabolic Syndrome 2023 15:180
  39. Type 2 diabetes (T2D) is a metabolic disease caused by the development of insulin resistance (IR), relative insulin deficiency, and hyperglycemia. Hyperglycemia-induced neurochemical dysregulation activates th...

    Authors: Nahi Sabih Alruwaili, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Ali K. Albuhadily, Amany E. Ragab, Ahmad Awad Alenazi, Athanasios Alexiou, Marios Papadakis and Gaber El-Saber Batiha
    Citation: Diabetology & Metabolic Syndrome 2023 15:179
  40. To evaluate the association of atherosclerotic cardiovascular disease (ASCVD) risk factors with incident ASCVD events among type 2 diabetes (T2D) individuals with microvascular complications.

    Authors: Yaxin Wang, Gabriella Bulloch, Yu Huang, Yingying Liang, Zijing Du, Guanrong Wu, Ying Fang, Yijun Hu, Xianwen Shang, Zhuoting Zhu, Xiayin Zhang, Xiaohong Yang and Honghua Yu
    Citation: Diabetology & Metabolic Syndrome 2023 15:178
  41. Central insulin resistance contributes to glaucoma development. Given the close association between metabolic syndrome MetS and insulin resistance, this study aimed to determine whether MetS is associated with...

    Authors: Jun-Hyuk Lee, Yu-Jin Kwon, Sung Jin Kim and Boyoung Joung
    Citation: Diabetology & Metabolic Syndrome 2023 15:177
  42. Age is a major risk factor associated with the complexity of coronary artery disease (CAD), and the prognosis of elderly patients with coronary heart disease is relatively poor. Metabolic disturbances are prev...

    Authors: Xiaona wang, Xinqiang Ji, Jianhui yu and Fan wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:176
  43. There are studies on the nutritional status of type 2 diabetes (T2D), but there are no large cohort studies on the prognosis of Controlling Nutritional Status (CONUT) score for T2D. The aim of this study was t...

    Authors: Dikang Pan, Julong Guo, Zhixiang Su, Jingyu Wang, Sensen Wu, Jianming Guo and Yongquan Gu
    Citation: Diabetology & Metabolic Syndrome 2023 15:175
  44. The studies of the effect of diabetes on the stiffness of Achilles tendon (AT) tissue remain inconclusive, we believe it is necessary to find a reliable method which can be used to detect the stiffness changes...

    Authors: Xinxin Huang, Xingyu Chen, Xiu Chen, Ping Chi, Pengfei Wang, Xiaomei Zhan, Chunpeng Zou, Liang Wang and Yanyan Dong
    Citation: Diabetology & Metabolic Syndrome 2023 15:174
  45. To assess the cost-effectiveness of utilizing IDegLira in comparison to other treatment regimens ( liraglutide and degludec) in managing type 2 diabetes, taking into account the Chinese healthcare system’s per...

    Authors: Ran Wei, Weihao Wang, Xiusheng Huang, Jingtao Qiao, Jinghe Huang, Chang Xing, Qi Pan and Lixin Guo
    Citation: Diabetology & Metabolic Syndrome 2023 15:173
  46. Patient navigation helps with better adherence to treatment, as well as better knowledge about diabetes and greater interest in performing, monitoring, and seeking health care. Therefore, this study aims to ev...

    Authors: Luciana Foppa, Betina Nemetz, Rosimeri de Matos, Josiane Schneiders, Gabriela Heiden Telo and Beatriz D. Schaan
    Citation: Diabetology & Metabolic Syndrome 2023 15:172
  47. Several observational cohorts and meta-analytical studies on humans have shown that users of sodium-glucose cotransporter-2 inhibitors (SGLT2is) have a lower risk for new-onset acute coronary syndrome (ACS) th...

    Authors: Tsung-Kun Lin, Mei-Chun Lee, Yu-Han Cheng, Timothy Ma, Mei-Chun Chen, Tsung-Yuan Yang and Gwo-Ping Jong
    Citation: Diabetology & Metabolic Syndrome 2023 15:170

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2022 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    84 days submission to accept (Median)

    2022 Usage 
    1,137,953 downloads
    3,375 Altmetric mentions